Nosocomial infections and agents determined by consultations in intensive care unit

Amaç: Reanimasyon I-II Yoğun Bakım Ünitelerinde, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı konsültasyonlarıyla tanı konulan nozokomiyal infeksiyonlar incelendi. Hastalar ve Yöntemler: Yoğun bakım ünitelerinde yatan 3750 hastanın 1221'i İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı konsültasyonlarıyla izlendi. Ayrıca yoğun bakıma yatış gerektiren primer ve diğer eşlik eden hastalıklar, demografik veriler, hastanede kalış ve izole edilen mikroorganizmalar da bu çalışmada değerlendirildi. Bulgular: Centers for Disease Control and Prevention kriterlerine göre 756 hasta (%61.9) nozokomiyal infeksiyon tanısı aldı. Bu infeksiyonlar arasında nozokomiyal pnömoni ilk sırada yer aldı. İnfeksiyon etkenleri olarak ilk sırada yer alan Pseudomonas spp.'i (%19.7), Acinetobacter spp. (%17.3) ve Staphylococcus spp. (%16.7) takip etti. Sonuç: Nozokomiyal infeksiyonlarla yoğun bakımlarda sık karşılaşılmaktadır. Bu infeksiyonlarda İnfeksiyon Hastalıkları konsültasyonları infeksiyon kontrolün yanısıra doğru ve hızlı tanı ve tedavide önem arz etmektedir.

Yoğun bakım ünitesinde konsültasyonlarla belirlenen hastane infeksiyonları ve etkenleri

Objectives: We investigated nosocomial infections diagnosed via consultations with the Department of Infectious Diseases and Clinical Microbiology at Reanimation I-II intensive care units. Patients and Methods: Of 3750 patients hospitalized at Reanimation I-II intensive care units, 1221 patients were followed up via consultations with the Department of Infectious Diseases and Clinical Microbiology. Additionally, main diseases that require intensive care, other concomitant diseases, demographical data, hospital stays and isolated microorganisms were evaluated. Results: Seven hundred and fifty-six patients (61.9%) were diagnosed with nosocomial infections according to the criteria of Centers for Disease Control and Prevention. Among these infections, nosocomial pneumonia took the first place. As infectious agent, Pseudomonas spp. (19.7%) took the first place, followed by Acinetobacter spp. (17.3%) and Staphylococcus spp. (16.7%). Conclusion: Nosocomial infections are common at intensive care units. Besides infection control precautions, consultations with Infectious Diseases are also important in quick identification and treatment of these infections.

___

  • 1) Edmond MB, Wenzel RP. Organization for infection control. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. New York: Elsevier Churchill Livingstone; 2005. p. 3323-6.
  • 2) Esposito S, Leone S. Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents 2007;29:494-500.
  • 3) Çetin ÇB, Turgut H, Kaleli İ, Yalçın AN, Orhan N. Pamukkale Üniversitesi Tıp Fakültesi Hastanesi yoğun bakım ünitesinde nozokomiyal infeksiyonlar. Hastane İnfeksiyonları Dergisi 2002;6.98-101.
  • 4) Beşirbellioğlu BA. Dünyada ve Türkiye'de infeksiyon hastalıkları konsültasyonları. Klimik Dergisi 2005;18:91-3.
  • 5) Eggimann P, Pittet D. Infection control in the ICU. Chest 2001;120:2059-93.
  • 6) Schlesinger Y, Paltiel O, Yinnon AM. Analysis and impact of infectious disease consultations in a general hospital. J Hosp Infect 1998;40:39-46.
  • 7) Petrak RM, Sexton DJ, Butera ML, Tenenbaum MJ, MacGregor MC, Schmidt ME, et al. The value of an infectious diseases specialist. Clin Infect Dis 2003;36:1013-7.
  • 8) Yapar N, Erdenizmenli M, Oğuz VA, Kuruüzüm Z, Senger SS, Cakir N, et al. Infectious disease consultations and antibiotic usage in a Turkish university hospital. Int J Infect Dis 2006;10:61-5.
  • 9) Akalin H, Kahveci F, Ozakin C, Helvaci S, Gedikoğlu S, Kutlay O, et al. Influences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICU. Intensive Care Med 1999;25:1010-2.
  • 10) Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44.
  • 11) Erbay H, Yalcin AN, Serin S, Turgut H, Tomatir E, Cetin B, et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med 2003;29:1482-8.
  • 12) Strausbaugh LJ. Nosocomial respiratory infections. In: Mandell GE, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York: Elsevier Churchill Livingstone; 2005. p. 3362-70.
  • 13) Namıduru M, Karaoğlan İ, Göksu S, Dikensoy Ö, Karaoğlan M. Cerrahi yoğun bakım ünitesinde hastane infeksiyonu etkeni olan bakteriler ve antibiyotiklere direnç durumları. İnfeksiyon Dergisi 2003;17:39-44.
  • 14) Palabıyıkoğlu İ, Tekeli E, Çokça F, Arıkan Akan Ö, Ünal N, Aysev D, et al. Ankara Üniversitesi Tıp Fakültesi hastaneleri yoğun bakım ünitelerinde hastane infeksiyonları sürveyansı: alet kullanım ve alet ilişkili infeksiyon oranları. Flora Dergisi 2006;11:89-95.
  • 15) Eltahawy AT. Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility. J Chemother 1997;9:403-10.
  • 16) Orrett FA. Nosocomial infections in an intensive care unit in a private hospital. West Indian Med J 2002;51:21-4.
  • 17) Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-92.
  • 18) Nag VL, Ayyagari A, Venkatesh V, Dash NR, Ghar M, Prasad KN. Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center. J Commun Dis 2005;37:281-7.
  • 19) Gastmeier P, Geffers C, Sohr D, Schwab F, Behnke M, Rüden H. Surveillance of nosocomial infections in intensive care units. Current data and interpretations. [Article in German] Wien Klin Wochenschr 2003;115:99-103.
  • 20) Warren JW. Nosocomial urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York: Elsevier Churchill Livingstone; 2005. p. 3370-81.
  • 21) Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000;21:510-5.
  • 22) Parlak E, Erol S, Kizilkaya M, Altoparlak U, Parlak M. Nosocomial urinary tract infections in the intensive care unit patients. [Article in Turkish] Mikrobiyol Bul 2007;41:39-49.
  • 23) Suljagić V, Cobeljić M, Janković S, Mirović V, Marković- Denić L, Romić P, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control 2005;33:333-40.
  • 24) Hopkins CC. Pharmacy service. In: Mayhall CG, editor. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 1315-22.
Trakya Üniversitesi Tıp Fakültesi Dergisi-Cover
  • ISSN: 1301-3149
  • Yayın Aralığı: Yılda 2 Sayı
  • Başlangıç: 2018
  • Yayıncı: -